EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation

Ziying Qiu, Rongkun Huang, Yuxuan Wu, Xinghao Li, Chunyu Sun, Yunqi Ma

Microbial Drug Resistance · 2024-06 · 30 (6) · 254-272

DOI: 10.1089/mdr.2023.0232 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Drug Resistance, online erschienen am 14.06.2024. Verfasst von Ziying Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Binzhou Medical University, Yantai, China. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 168 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating crisis of antimicrobial resistance (AMR) underscores the urgent need for novel antimicrobials. One promising strategy is the exploration of structural diversity, as diverse structures can lead to diverse biological activities and mechanisms of action. This review delves into the role of structural diversity in antimicrobial discovery, highlighting its influence on factors such as target selectivity, binding affinity, pharmacokinetic properties, and the ability to overcome resistance mechanisms. We discuss various approaches for exploring structural diversity, including combinatorial chemistry, diversity-oriented synthesis, and natural product screening, and provide an overview of the common mechanisms of action of antimicrobials. We also describe techniques for investigating these mechanisms, such as genomics, proteomics, and structural biology. Despite significant progress, several challenges remain, including the synthesis of diverse compound libraries, the identification of active compounds, the elucidation of complex mechanisms of action, the emergence of AMR, and the translation of laboratory discoveries to clinical applications. However, emerging trends and technologies, such as artificial intelligence, high-throughput screening, next-generation sequencing, and open-source drug discovery, offer new avenues to overcome these challenges. Looking ahead, we envisage an exciting future for structural diversity-oriented antimicrobial discovery, with opportunities for expanding the chemical space, harnessing the power of nature, deepening our understanding of mechanisms of action, and moving toward personalized medicine and collaborative drug discovery. As we face the continued challenge of AMR, the exploration of structural diversity will be crucial in our search for new and effective antimicrobials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryHumansAnti-Bacterial AgentsStructure-Activity RelationshipAnti-Infective AgentsBiological ProductsHigh-Throughput Screening Assays

Stichwörter der Autor:innen

antimicrobial discoveryantimicrobial resistancedrug discovery techniquesmechanism of actionstructural diversity

Substanzen

Anti-Bacterial AgentsAnti-Infective AgentsBiological Products

Autor:innen und Institutionen

  • School of Pharmacy, Binzhou Medical University, Yantai, China.

Zitieren

APA

Qiu, Z., Huang, R., Wu, Y., Li, X., Sun, C., & Ma, Y. (2024). Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation. Microbial Drug Resistance, 30(6), 254-272. https://doi.org/10.1089/mdr.2023.0232

Vancouver

Qiu Z, Huang R, Wu Y, Li X, Sun C, Ma Y. Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation. Microbial Drug Resistance. 2024;30(6):254-272. doi:10.1089/mdr.2023.0232

BibTeX
@article{Qiu2024,
  author = {Qiu, Ziying and Huang, Rongkun and Wu, Yuxuan and Li, Xinghao and Sun, Chunyu and Ma, Yunqi},
  title = {Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation},
  journal = {Microbial Drug Resistance},
  year = {2024},
  volume = {30},
  number = {6},
  pages = {254--272},
  doi = {10.1089/mdr.2023.0232}
}
Kostenlos starten →